Nubar Afeyan’s Company Tests Skin Cancer Vaccine: Risk of Recurrence Falls by 42%
The vaccine is personalized for each patient based on the genetic mutations found in their tumor. It is designed to train the immune system to recognize and destroy cancer cells...

more news
browse by date